Quinten Health

Event: EADV Congress 2026, Vienna, Austria Authors: Mina Farah, Nikkia Zarabian, Savanna I. Vidal, Nikita Menta, Julien Dauriat, Guillaume Bourdon, Quentin Pilard, Kahina Lounaci, Krzysztof Piotrowski, Nadège Lachmann, Adam Friedman View Poster The post S

.qh-blog-container { color: #2E0F3A; font-size: 16px; line-height: 1.7; font-family: inherit; } .qh-blog-container h1 { color: #4F105E; font-size: 32px; font-weight: 700; margin-top: 25px; margin-bottom: 15px; line-height: 1.3; } .qh-blog-container h2 { c

.qh-post { color: #2E0F3A; font-size: 16px; line-height: 1.6; font-family: inherit; } .qh-post h2 { color: #4F105E; font-size: 22px; font-weight: 600; margin-top: 35px; margin-bottom: 20px; border-left: 4px solid #F39283; padding-left: 12px; } .qh-post p

When head-to-head evidence is unavailable, conventional Indirect Treatment Comparisons (ITCs) can estimate the relative effects of competing treatments through a shared comparator. A Bucher adjusted indirect comparison combines treatment effects from two

RCTs not feasible? Think External Control Arms (ECAs)! The context: Beyond the Gold Standard Randomized Controlled Trials (RCTs) remain the gold standard to assess treatment effect. But they are sometimes impractical or even unfeasible, especially in rare

Transforming Fragmented Data into Robust, Actionable Evidence In clinical research and healthcare decision-making, a single study can provide valuable insights. However, relying on isolated data often leaves gaps. To build truly robust, credible, and acti

Publisher: BMC Cancer Authors: Rana Jreich, Paul Loustalot, Sacha Levy, Kahina Lounaci, Ruiyi Yuan, Helgi Van de Velde, Zhaoling Meng View Article Background The underrepresentation of key populations in clinical trials can create critical gaps in our und

Building Decision-Grade Evidence in Complex Clinical Contexts How Quinten Health supports clinical, regulatory, and access decisions with a patient-centric framework Why "complex contexts" require a different evidence strategy In many therapeutic areas, t

Accelerating Systematic Literature Reviews: How AI is redefining Evidence-Based Medicine Systematic Literature Reviews (SLRs) remain the gold standard for evidence-based medicine. However, the traditional process faces a significant hurdle: the manual scr

Quinten Health Recognized in the Prestigious HealthTech 250 by Galen Growth We are thrilled to announce that Quinten Health has been officially selected for the HealthTech 250 (Europe 2026) cohort by Galen Growth. This recognition places us among the most